Search Results

Jacob Lee and Jin Cho, co-founders of GeneMode, on the ten billion dollars American labs waste every In this conversation, Jacob Lee and Jin Cho — co-founders of GeneMode — describe what they saw when they About the Guests Jacob Lee is the CEO and co-founder of GeneMode. He trained as a bioengineer and worked as a research scientist in stem cell and cancer labs before founding Jin Cho is the CTO and co-founder of GeneMode.

Built for founders who prefer clarity over chaos and confusion.

Built for founders who prefer clarity over chaos and confusion.

Built for founders who prefer clarity over chaos and confusion.

The foundation of this program rests on a serendipitous discovery Boucard made in Thomas Südhof's lab That discovery became the foundation of Boucard's independent research program. 4.

Jean-Philippe Pin on the web LinkedIn ResearchGate CNRS Fondation Bettencourt Schueller FRC Neurodon

Biotech founder Ajay Yekkirala shares how AI, GPCRs, and bold questions are driving next-gen pain therapeutics Ajay Yekkirala is a GPCR pharmacologist, biotech entrepreneur, and co-founder of Superluminal Medicines PhD application rerouted his path toward a breakthrough GPCR research career The inside story behind founding Ajay Yekkirala is a molecular pharmacologist, biotech founder, and scientist whose career has been defined Seeing the limits of traditional drug discovery, he later co-founded Superluminal Medicines, a company

Built for teams aligning pharmacology across programs — so everyone works from the same expert-led foundation

That said, the presenters are skilled at making complex science accessible, and the Q&A often covers foundational

Mike Caterina laid the foundation. But the deeper mission? Underestimated Role of RGS Proteins in Pain Although not a self-proclaimed GPCR specialist, Serafini found “We’re using outdated drugs. There are more elegant GPCR targets waiting to be explored.” him, especially those who shared administrative, grant-writing, and leadership skills early on, he found

That curiosity laid the foundation for a broader investigation into receptor activity-modifying proteins From Curiosity to Collaboration “We decided to evaluate the multiplexing methods... and found this Luminex

the context of pain and inflammation, and how his PhD research on non-canonical GPCR roles laid the foundation

You'll Be in Good Company From PhDs to CRO execs to rising biotech founders—this is a vetted, mission-aligned Start Your Journey Today Meet the Leadership Founder & Director Yamina Berchiche Get in Touch Board Member Quinn Get in Touch Board Member Maria Waldhoer Get in Touch Co-Founder Attila Foris Get in Touch Board

See how we can help you About Timeline Strategy Founded by Attila Foris, Timeline Strategy partners with to increase optionality and reduce risk. 👉 This is where str Attila Foris Feb 23 The Moment Biotech Founders Realize the Money Is Gone 👉 Most biotech founders do not realize they are in trouble when the money

GPCR podcast , your host and founder, Dr.

Chris Tate co-founded Heptares after reading one paper on a Friday afternoon. systematic mutation screen, a 21-degree improvement in receptor thermostability, and eventually the co-founding He co-founded Heptares (now Sosei Heptares) in 2007, a company that has since produced over 250 GPCR That stability was what made crystallization tractable and what became the foundation of Heptares. Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by

Berchiche is the founder of Dr.

Andrew Tobin draws from his experience leading translational GPCR programs and co-founding Keltic Pharma As co-founder and CEO of Keltic Pharma Therapeutics, he leads a biotechnology company developing a novel

the postdoc in Bob Lefkowitz's lab during the molecular biology revolution in GPCR science, and the foundational student testing the effect of nephrogenic diabetes insipidus mutations on the V2 vasopressin receptor found

His early work at Wyeth's Women's Health Research Institute produced foundational observations on biased

Masterclasses cover a variety of track including but not limited to pharmacology foundations, agonists

Despite decades of study, the field remains divided on a foundational question: are frizzled receptors

Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for

Scott Struthers, Ph.D., is our co-founder and has served as our President and Chief Executive Officer Prior to Neurocrine, from 1995 to 1998, he co-founded ScienceMedia Inc. to develop eLearning solutions Struthers co-founded and serves as board chair at Radionetics Oncology, a pharmaceutical company focused Entrepreneurs Exchange, a nonprofit organization that provides resources for early-stage start-ups, which he co-founded

Sri is a co-founder at Octant and an Associate Professor at UCLA in the Chemistry and Biochemistry Department

He is the scientific founder of two biotech companies, ModMab Therapeutics , and AntlerA Therapeutics

Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

Berchiche is the founder of Dr.

He also directs a collaborative neuroscience R&D program with Servier (France) and is the co-founder

Lauren Solano, CEO and co-founder of Propel Careers, has spent more than a decade coaching PhDs and postdocs About the Guest Lauren Solano is CEO and co-founder of Propel Careers, a Boston-based firm that coaches first decade in preclinical and early clinical drug discovery before pursuing an MBA in 2007 and co-founding consistently undersell their transferable skills After thousands of conversations with scientists, Solano has found